Latest News by Industry
DUBLIN--(BUSINESS WIRE)--Oct 28, 2022--
The "Interventional Cardiology Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering.
The global interventional cardiology devices market reached a value of US$ 19.58 Billion in 2021. Looking forward, the publisher expects the market to reach a value of US$ 32.21 Billion by 2027, exhibiting a CAGR of 8.65% during 2021-2027.
Companies Mentioned
Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Interventional cardiology devices refer to the medical equipment and guiding tools used for performing cardiovascular procedures, such as angioplasty and stenting. Some of the commonly used devices include angioplasty balloons, stents, mitral, pulmonary and tricuspid valves, catheters, plaque modification and hemodynamic flow alteration devices. Along with this, guidewires, vascular closure and hemostasis devices and introducer sheaths are also utilized.
These tools and devices are widely used for medical procedures, such as coronary artery bypass grafting (CABG), trans-myocardial laser revascularization (TMR), arrhythmia treatment, aneurysm repair, open-heart, off-pump heart and minimally invasive (MI) heart surgeries. They are also used for other procedures, such as atherectomy, embolic protection and percutaneous valve repair.
The increasing prevalence of diabetes, hypertension and cardiovascular disorders, such as coronary artery disease (CAD, is one of the key factors driving the growth of the market. Moreover, the rising geriatric population, which is more susceptible to such ailments, is providing a thrust to the market growth. Interventional cardiology and embolic protection devices are widely used to capture embolic debris to ensure continuous blood flow and preventing blockages.
Additionally, the development of innovative bioabsorbable and drug-eluting stents, pacemakers and drug-coated mesh tubes is acting as another growth-inducing factor. In line with this, the increasing utilization of advanced imaging solutions, such as intravenous ultrasound (IVUS), fractional flow reserve (FFR) and optical coherence tomography (OCT) for early diagnosis and timely treatment of cardiovascular ailments, is also contributing to the growth of the market.
Other factors, including rising healthcare expenditure capacities of the masses, along with extensive improvements in the medical infrastructure, especially in the developing economies, are anticipated to drive the market toward growth.
Key Market Segmentation:
The publisher provides an analysis of the key trends in each sub-segment of the global interventional cardiology devices market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product and end user.
Breakup by Product:
Breakup by End User:
Breakup by Region:
Key Questions Answered in This Report:
For more information about this report visit https://www.researchandmarkets.com/r/8ot16v
View source version on businesswire.com:https://www.businesswire.com/news/home/20221028005176/en/
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
KEYWORD:
INDUSTRY KEYWORD: MEDICAL DEVICES HEALTH
SOURCE: Research and Markets
Copyright Business Wire 2022.
PUB: 10/28/2022 04:56 AM/DISC: 10/28/2022 04:56 AM
http://www.businesswire.com/news/home/20221028005176/en